Description and efficacy of the main clinical models (not requiring instrumental tests) in identification of low- and high-risk patients with pulmonary embolism
| Model . | Reference . | No. of items in the model . | Fixed value for items in the model . | Low-risk patients according to the model . | Validation . | Management study . | |
|---|---|---|---|---|---|---|---|
| Prevalence . | 30-d mortality (95% CI) . | ||||||
| PESI, 2010 | 17 | 11 | No | 19.4 | Class I: 1.1% (0.7-1.7) | Yes | Yes |
| 21.5 | Class II: 3.1% (2.5-4.0) | ||||||
| sPESI, 2010 | 18 | 6 | Yes | 36.1 | 1.0% (0.0-2.1) | Yes | No |
| Hestia, 2011 | 19 | 11 | Yes | na | 1.0% (0.2-2.9)* | Yes | Yes |
| RIETE, 2007 | 20 | 7† | No | 47.8 | 1.63% (1.39-1.92) | Yes | No |
| Model . | Reference . | No. of items in the model . | Fixed value for items in the model . | Low-risk patients according to the model . | Validation . | Management study . | |
|---|---|---|---|---|---|---|---|
| Prevalence . | 30-d mortality (95% CI) . | ||||||
| PESI, 2010 | 17 | 11 | No | 19.4 | Class I: 1.1% (0.7-1.7) | Yes | Yes |
| 21.5 | Class II: 3.1% (2.5-4.0) | ||||||
| sPESI, 2010 | 18 | 6 | Yes | 36.1 | 1.0% (0.0-2.1) | Yes | No |
| Hestia, 2011 | 19 | 11 | Yes | na | 1.0% (0.2-2.9)* | Yes | Yes |
| RIETE, 2007 | 20 | 7† | No | 47.8 | 1.63% (1.39-1.92) | Yes | No |